Author: Abhay Panchal

AT DDW 2023CHICAGO – In this age of corporate megamergers, private practice gastroenterologists are increasingly weighing the pros and cons of selling their practices to private equity firms. It’s becoming more difficult for solo or small group practices to go it alone. While there may be advantages in selling a medical practice to a private equity firm, physicians could be trading a degree of freedom for financial certainty and relief from administrative burdens, according to Klaus Mergener, MD, PhD, MBA, AGAF, a clinical gastroenterologist, affiliate professor of medicine at the University of Washington, Seattle, and chief medical officer of Pentax…

Read More

Millions of adults experience gut health issues and in response, numerous gut health companies have emerged, offering specialized products and services to address individual needs—meanwhile, Alba Health is one pioneering company that stands out by focusing on the future generation’s well-being. The Danish-Swedish start-up is devoted to providing digital gut health support for children, empowering parents to raise a healthier and more resilient generation. According to Alba Health, “Gut health in the first years of life is linked to common symptoms and chronic conditions later in life.”

Read More

INTRODUCTIONMost of us have experienced self-doubt at some point in our lives. We may not feel as competent or knowledgeable as colleagues and friends perceive us to be, or may frequently attribute our success to chance. This destructive state of being is sometimes referred to as the imposter phenomenon, and almost 70% of people have felt some degree of imposter syndrome.1 It particularly affects high-achieving individuals in academic settings, such as PhD students, postdoctoral scientists, and clinicians at all levels of training. Prevalence appears to be increased among people from minority backgrounds who are underrepresented in medicine and academia.2 Studies…

Read More

Private equity ownership of medical practices was linked to consumer price increases for 8 of 10 specialties examined in a new report, with the most notable gains reported for oncology and gastroenterology. The report was a collaboration of UC Berkeley staff and researchers from two nonprofits, the American Antitrust Institute and the Washington Center for Equitable Growth. It provides “convincing evidence that incentives to put profits before patients have grown stronger with an increase in private equity ownership of physician practices,” said lead author Richard Scheffler, PhD, of UC Berkeley in a statement. The report also noted that private equity…

Read More

ATLANTA, July 27, 2023 /PRNewswire/ — Hetal A. Karsan, MD, an Atlanta Gastroenterology Associates physician, has been elected as the newest Governor of Georgia for the American College of Gastroenterology (ACG). Dr. Karsan will serve a term of three years. Dr. Karsan is a graduate of Indiana University and earned his Doctor of Medicine from the Indiana University School of Medicine. He completed his internship and residency at Boston University Medical Center. Dr. Karsan pursued clinical fellowships in gastroenterology and hepatology at the University of California, Los Angeles (UCLA) Medical Center, with additional formal training in interventional endoscopy, liver transplantation…

Read More

On Thursday, CareCloud, Inc. announced a landmark collaboration with Google Cloud to enable revolutionary generative AI technology and capabilities to benefit small and medium sized healthcare practices and outpatient providers. Needless to say, Google Cloud is an industry titan and has made significant strides in not only the AI space, but has also achieved compelling progress in its healthcare work. CareCloud is known for its extensive work with small and medium sized healthcare organizations and its significant experience with technology based revenue cycle management, digital health, and provider services. Given its work in the industry for nearly two decades, CareCloud…

Read More

Even though nonalcoholic fatty liver disease is the most common form of chronic liver disease in the United States, there are unfortunately no FDA-approved medications for this condition. That’s why Dr. Peter Buch speaks with Dr. Sidney Barritt about even more treatment strategies for nonalcoholic fatty liver disease in the second and final part of this two-episode series. Dr. Barritt is an Associate Professor of Medicine and the Director of Hepatology at the UNC Liver Center at the University of North Carolina.

Read More

Exact Sciences plans to seek approval soon of an updated Cologuard stool-based colon cancer screening test and launch a blood test to detect cancer that can linger after surgery. The Madison-based company is also developing blood tests to screen for colon cancer and for many types of cancer at once. But whether it starts a large, expensive study of its multi-cancer screening test next year could depend on whether Congress tells Medicare to pay for it.

Read More